Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Carbohydrate-based immune adjuvants.

Petrovsky N, Cooper PD.

Expert Rev Vaccines. 2011 Apr;10(4):523-37. doi: 10.1586/erv.11.30. Review.

2.

Polysaccharides: Candidates of promising vaccine adjuvants.

Li P, Wang F.

Drug Discov Ther. 2015 Apr;9(2):88-93. doi: 10.5582/ddt.2015.01025. Review.

3.

Carbohydrate-based vaccine adjuvants - discovery and development.

Hu J, Qiu L, Wang X, Zou X, Lu M, Yin J.

Expert Opin Drug Discov. 2015 Oct;10(10):1133-44. doi: 10.1517/17460441.2015.1067198. Epub 2015 Sep 15. Review.

PMID:
26372693
4.

Alum adjuvant: some of the tricks of the oldest adjuvant.

Kool M, Fierens K, Lambrecht BN.

J Med Microbiol. 2012 Jul;61(Pt 7):927-34. doi: 10.1099/jmm.0.038943-0. Epub 2011 Dec 15. Review.

PMID:
22174375
5.

Contamination of DNase Preparations Confounds Analysis of the Role of DNA in Alum-Adjuvanted Vaccines.

Noges LE, White J, Cambier JC, Kappler JW, Marrack P.

J Immunol. 2016 Aug 15;197(4):1221-30. doi: 10.4049/jimmunol.1501565. Epub 2016 Jun 29.

6.

Lipid and carbohydrate based adjuvant/carriers in immunology.

McGeary RP, Olive C, Toth I.

J Pept Sci. 2003 Jul;9(7):405-18. Review.

PMID:
12916638
7.

Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3.

Li H, Willingham SB, Ting JP, Re F.

J Immunol. 2008 Jul 1;181(1):17-21.

8.

Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs.

Petrovsky N.

Drug Saf. 2015 Nov;38(11):1059-74. doi: 10.1007/s40264-015-0350-4. Review.

9.

New generation adjuvants--from empiricism to rational design.

O'Hagan DT, Fox CB.

Vaccine. 2015 Jun 8;33 Suppl 2:B14-20. doi: 10.1016/j.vaccine.2015.01.088. Review.

PMID:
26022561
10.

Adjuvants in veterinary vaccines: modes of action and adverse effects.

Spickler AR, Roth JA.

J Vet Intern Med. 2003 May-Jun;17(3):273-81. Review.

11.

Novel human polysaccharide adjuvants with dual Th1 and Th2 potentiating activity.

Petrovsky N.

Vaccine. 2006 Apr 12;24 Suppl 2:S2-26-9. Review.

12.

Trends in vaccine adjuvants.

Schijns VE, Lavelle EC.

Expert Rev Vaccines. 2011 Apr;10(4):539-50. doi: 10.1586/erv.11.21. Review.

PMID:
21506650
13.

Combination adjuvants: the next generation of adjuvants?

Mutwiri G, Gerdts V, van Drunen Littel-van den Hurk S, Auray G, Eng N, Garlapati S, Babiuk LA, Potter A.

Expert Rev Vaccines. 2011 Jan;10(1):95-107. doi: 10.1586/erv.10.154. Review.

PMID:
21162624
14.

Adjuvant activities of saponins from traditional Chinese medicinal herbs.

Song X, Hu S.

Vaccine. 2009 Aug 6;27(36):4883-90. doi: 10.1016/j.vaccine.2009.06.033. Epub 2009 Jun 24. Review.

PMID:
19559122
15.

The role of adjuvants in retroviral vaccines.

Vogel FR.

Int J Immunopharmacol. 1995 Feb;17(2):85-90. Review.

PMID:
7657411
16.

Alum's adjuvant action: grease is the word.

Mbow ML, De Gregorio E, Ulmer JB.

Nat Med. 2011 Apr;17(4):415-6. doi: 10.1038/nm0411-415. No abstract available.

PMID:
21475229
17.

Calcium phosphate: a substitute for aluminum adjuvants?

Masson JD, Thibaudon M, Bélec L, Crépeaux G.

Expert Rev Vaccines. 2017 Mar;16(3):289-299. doi: 10.1080/14760584.2017.1244484. Epub 2016 Oct 24. Review.

PMID:
27690701
18.

The impact of size on particulate vaccine adjuvants.

Shah RR, O'Hagan DT, Amiji MM, Brito LA.

Nanomedicine (Lond). 2014 Dec;9(17):2671-81. doi: 10.2217/nnm.14.193.

PMID:
25529570
19.

Adjuvants for human vaccines--current status, problems and future prospects.

Gupta RK, Siber GR.

Vaccine. 1995 Oct;13(14):1263-76. Review.

PMID:
8585280
20.

An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants.

Fox CB, Haensler J.

Expert Rev Vaccines. 2013 Jul;12(7):747-58. doi: 10.1586/14760584.2013.811188. Review.

PMID:
23885820

Supplemental Content

Support Center